Delivery Order SPE2DB20D2104-SPE2DB22FT96V
- Not listed
- This federal contract award, valued at $5,075.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,524,187 units of the medication Vyvanse 10 mg capsules. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, with a ceiling value of $999,999,999. This single-award IDC serves as the primary vehicle for Cencora, Inc....
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,562,306,642 units of Vyvanse 70 mg capsules. The firm-fixed-price delivery order, valued at $1,964.75, has an ultimate completion date of September 27, 2023. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,667.23 award is for the supply of Vyvanse 50 mg capsules, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC...
- This federal contract award, valued at $17,124.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for Vyvanse 60 mg capsules in 100-count bottles. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc., which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award of $4,391.45 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,702,723 units of the medication Vyvanse 10 mg capsules. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,456.05 firm fixed-price delivery order covers the supply of 100 units of the 60 milligram capsule form of the pharmaceutical drug Vyvanse. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which enables Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $1,318.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,450,813 units of the pharmaceutical product Vyvanse 40 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical,...
- This federal contract award, valued at $2,108.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the delivery of 4,559,786,330 units of the medication Vyvanse 10 mg capsules. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4560942334 Vyvanse 30 mg capsules. The $3,337.38 firm-fixed-price delivery order has a completion date of May 16, 2023. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,783.16, is for the delivery of 4,559,522,849 units of the medication Vyvanse 10 mg chewable tablets. The award is not designated as a set-aside contract and was made through full and open competition. Amerisourcebergen, a major pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT96VDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,685.23 firm fixed-price delivery order provides the DLA with 4,558,503,628 units of the prescription medication Vyvanse 10 mg capsules. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials, to support military and veteran healthcare programs globally. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. As a major pharmaceutical distributor, Cencora, Inc. and its Amerisourcebergen Drug Corp subsidiary play a critical role in supplying essential medical products to the U.S. Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/19/22 |